CALR:

Aleksandra Mroczkowska-Bękarciak1, Agnieszka Szeremet2, Olga Chyrko2

  • 1Department and Clinic of Hematology, Cellular Therapies and Internal Medicine, Wroclaw Medical University, Wroclaw, Poland. omroczkowska@interia.pl.

Journal of applied genetics
|February 17, 2025
PubMed
概括

下一代测序 (NGS) 在近一半患有CALR阳性髓增殖新生瘤 (MPNs) 的患者中发现了额外的突变. 这些共存的突变,特别是ASXL1,TET2和DNMT3A,影响了MPN的预后和治疗策略.